Metraipolis › archive › dc_c8ba555e80f0

Pembrolizumab-Induced Tubulointerstitial Nephritis in Early-Stage Triple-Negative Breast Cancer: A Case Report — Europe PMC PMID:41510480

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41510480
DOI
10.7759/cureus.98726
License (as archived)
solo-consultazione
Archived
2026-11-07T19:56:31.467Z
SHA-256 of the archived text
80a05221d078fb229853accd28add9fa5a7d7a3922629d17679c35ef3db881b0
Stable URL of this page
https://metraipolis.com/documento/dc_c8ba555e80f0

How to cite

Pembrolizumab-Induced Tubulointerstitial Nephritis in Early-Stage Triple-Negative Breast Cancer: A Case Report — Europe PMC PMID:41510480 — Europe PMC (en), https://europepmc.org/article/MED/41510480 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c8ba555e80f0 (Metraipolis archive dc_c8ba555e80f0, sha256 80a05221d078fb229853accd28add9fa5a7d7a3922629d17679c35ef3db881b0)
BibTeX
@misc{dcc8ba555e80f0,
  title = {Pembrolizumab-Induced Tubulointerstitial Nephritis in Early-Stage Triple-Negative Breast Cancer: A Case Report — Europe PMC PMID:41510480},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41510480},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c8ba555e80f0; sha256 80a05221d078fb229853accd28add9fa5a7d7a3922629d17679c35ef3db881b0},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41510480. Agents can read the archived copy with the MCP tool read_document.